Novavax shares fall as much as 32% after releasing early trial data on coronavirus vaccine – CNBC

Novavax announced Tuesday its potential vaccine to prevent Covid-19 produced an appealing immune reaction in an early-stage clinical trial, however the biotech companys stock fell on concerns about its … [+3470 chars]